True Rx and Capital Rx partner with Aranscia (AccessDx and YouScript) to provide the AccessDx PGx profile, a genomic test that evaluates drug-gene interactions and variations. This at-home test, conducted with a simple cheek swab, examines around 30 genes to tailor medications for antidepressants, statins, and blood pressure drugs. By pinpointing common and rare ethno-specific variations, this testing has the potential to transform medication prescribing practices. Patients receive a prepaid envelope for easy test return, ensuring convenience and accessibility. This collaboration could reshape medication prescribing practices by leveraging genomics testing to optimize drug selection.
Read more from managedhealthcareexecutive.com